Results - Announcements
Parmax Pharma reports standalone net loss of Rs 0.22 crore in the September 2024 quarter As on : 16-Nov-24  07:38

Net Loss of Parmax Pharma reported to Rs 0.22 crore in the quarter ended September 2024 as against net loss of Rs 1.37 crore during the previous quarter ended September 2023. Sales rose 128.01% to Rs 9.28 crore in the quarter ended September 2024 as against Rs 4.07 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	9.28	4.07	128
OPM %	2.05	-18.92	-
PBDT	0.18	-0.94	LP
PBT	-0.22	-1.37	84
NP	-0.22	-1.37	84

Powered by Capital Market - Live News